Skenan



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 20.5%
Pain 17.9%
Analgesic Therapy 10.3%
Bone Pain 10.3%
Pain In Extremity 10.3%
Chemotherapy 7.7%
Abdominal Pain Upper 5.1%
Glaucoma 5.1%
Knee Arthroplasty 2.6%
Multiple Myeloma 2.6%
Phlebitis 2.6%
Prostate Cancer 2.6%
Sciatica 2.6%
Fall 11.1%
Hepatocellular Injury 11.1%
Metabolic Acidosis 11.1%
Overdose 11.1%
Renal Failure 11.1%
Somnolence 11.1%
Thrombocytopenia 11.1%
Urinary Retention 11.1%
Vomiting 11.1%
Secondary
Drug Use For Unknown Indication 34.7%
Product Used For Unknown Indication 27.7%
Pain 13.1%
Cancer Pain 3.4%
Rheumatoid Arthritis 2.1%
Prostate Cancer 2.0%
Hypertension 1.8%
Bronchial Disorder 1.7%
Back Pain 1.5%
Insomnia 1.5%
Anxiety 1.3%
Depression 1.3%
Oral Neoplasm 1.3%
Abdominal Pain 1.2%
Bone Pain 1.1%
Multiple Myeloma 1.1%
Sciatica 1.1%
Hypercholesterolaemia 0.8%
Muscle Spasms 0.8%
Osteoporosis 0.8%
Renal Failure Acute 11.8%
Vomiting 8.4%
Urinary Retention 7.6%
Confusional State 6.7%
Road Traffic Accident 6.7%
Hepatocellular Injury 5.9%
Somnolence 5.9%
Cholestasis 5.0%
Pyrexia 5.0%
Respiratory Distress 5.0%
Toxic Skin Eruption 5.0%
Fall 3.4%
Sepsis 3.4%
Syndactyly 3.4%
Toxicity To Various Agents 3.4%
Transaminases Increased 3.4%
Drug Dependence 2.5%
Miosis 2.5%
Ovarian Cancer 2.5%
Pierre Robin Syndrome 2.5%
Concomitant
Product Used For Unknown Indication 22.5%
Drug Use For Unknown Indication 18.3%
Pain 17.4%
Prophylaxis 3.8%
Multiple Myeloma 3.4%
Gastric Cancer 3.0%
Hypertension 2.9%
Hiv Infection 2.8%
Back Pain 2.7%
Non-small Cell Lung Cancer 2.4%
Osteoporosis 2.4%
Depression 2.2%
Thrombosis Prophylaxis 2.2%
Anxiety 2.2%
Constipation 2.1%
Ankylosing Spondylitis 2.1%
Plasma Cell Myeloma 2.0%
Rheumatoid Arthritis 1.9%
Unevaluable Event 1.9%
Bone Pain 1.8%
Vomiting 13.3%
Pyrexia 8.0%
Thrombocytopenia 7.6%
Somnolence 6.8%
Renal Failure Acute 6.5%
Weight Decreased 6.5%
Neutropenia 4.9%
Pulmonary Embolism 4.9%
Cytolytic Hepatitis 4.2%
Tachycardia 4.2%
Toxic Skin Eruption 4.2%
General Physical Health Deterioration 3.8%
Sepsis 3.8%
Pancytopenia 3.4%
Malaise 3.0%
Oedema 3.0%
Pulmonary Hypertension 3.0%
Renal Failure 3.0%
Tooth Extraction 3.0%
Rhabdomyolysis 2.7%
Interacting
Product Used For Unknown Indication 40.7%
Drug Use For Unknown Indication 25.9%
Amputation Stump Pain 11.1%
Neuralgia 7.4%
Pain 7.4%
Ankylosing Spondylitis 3.7%
Confusional State 3.7%
Respiratory Depression 28.6%
Death 14.3%
Drug Interaction 14.3%
Partial Seizures 14.3%
Respiratory Distress 14.3%
Suicide Attempt 14.3%